Literature DB >> 19892411

HDAC2: a critical factor in health and disease.

Oliver H Krämer1.   

Abstract

Histone deacetylases control cellular signaling and gene expression. Histone deacetylase 2 (HDAC2) is crucial for embryonic development, affects cytokine signaling relevant for immune responses and is often significantly overexpressed in solid tumors. Nevertheless, transformed cells lacking HDAC2 due to somatic mutations have recently been discovered. This finding has raised a question regarding the functions of this enzyme. Detailed analyses of the molecular mechanisms governing gene regulation by HDAC2 illustrate how this protein influences proliferation, apoptosis and differentiation of cells. Beyond clarifying the role of HDAC2 for cellular fate, such data position the epigenetic regulator HDAC2 as a therapeutically important prognostic marker that can be subjected to pharmacological control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892411     DOI: 10.1016/j.tips.2009.09.007

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  53 in total

Review 1.  Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Roland M Schmid; Dieter Saur
Journal:  J Gastrointest Cancer       Date:  2011-06

2.  Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction.

Authors:  David Adenuga; Samuel Caito; Hongwei Yao; Isaac K Sundar; Jae-Woong Hwang; Sangwoon Chung; Irfan Rahman
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

3.  Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.

Authors:  Jing Zhang; Shu Kan; Brian Huang; Zhenyue Hao; Tak W Mak; Qing Zhong
Journal:  Genes Dev       Date:  2011-10-20       Impact factor: 11.361

4.  HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND).

Authors:  Zainulabedin M Saiyed; Nimisha Gandhi; Marisela Agudelo; Jessica Napuri; Thangavel Samikkannu; Pichili V B Reddy; Pradnya Khatavkar; Adriana Yndart; Shailendra K Saxena; Madhavan P N Nair
Journal:  Neurochem Int       Date:  2011-02-17       Impact factor: 3.921

5.  Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs.

Authors:  Lukáš Tenora; Jesse Alt; Ranjeet P Dash; Alexandra J Gadiano; Kateřina Novotná; Vijayabhaskar Veeravalli; Jenny Lam; Quinn R Kirkpatrick; Kathryn M Lemberg; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  J Med Chem       Date:  2019-03-29       Impact factor: 7.446

6.  Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.

Authors:  Hongyu Gao; Huihan Wang; Wei Yang
Journal:  Int J Hematol       Date:  2017-03-18       Impact factor: 2.490

7.  Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.

Authors:  Shuai Gao; Jie Zang; Qianwen Gao; Xuewu Liang; Qinge Ding; Xiaoyang Li; Wenfang Xu; C James Chou; Yingjie Zhang
Journal:  Bioorg Med Chem       Date:  2017-03-19       Impact factor: 3.641

Review 8.  Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

9.  HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells.

Authors:  Susanne Schüler; Petra Fritsche; Sandra Diersch; Alexander Arlt; Roland M Schmid; Dieter Saur; Günter Schneider
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

Review 10.  The emerging role of the ubiquitin proteasome in pulmonary biology and disease.

Authors:  Nathaniel M Weathington; Jacob I Sznajder; Rama K Mallampalli
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.